People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pulmatrix Inc | — | Biotechnology | Series B | $69.6M | $396.9M | 2011 |
Robert T. Clarke at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert T. Clarke on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven Gillis | 1 | 23 |
| Michael Higgins | 1 | 9 |
| SCOTT ROCKLAGE | 1 | 9 |
| Terrance McGuire | 1 | 9 |
| Robert Clarke | 1 | 7 |
| Kurt Graves | 1 | 5 |
| Robert Connelly | 1 | 4 |
| Lauren T Silverman | 1 | 3 |
| David Edwards | 1 | 3 |
| David T Maki | 1 | 2 |
| David Maki | 1 | 2 |
| David Hava | 1 | 2 |
| Mark T Gabrielson | 1 | 1 |
| Scott T Rocklage | 1 | 1 |
| David T Edwards | 1 | 1 |
| Terry T McGuire | 1 | 1 |
| Steven T Gillis | 1 | 1 |
| Robert T Connelly | 1 | 1 |
| Kurt T Graves | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.